Impaired Irs–1/Pi3–Kinase Signaling in Patients With Hcv: A Mechanism for Increased Prevalence of Type 2 Diabetes
Open Access
- 30 December 2003
- journal article
- Published by Wolters Kluwer Health in Hepatology
- Vol. 38 (6), 1384-1392
- https://doi.org/10.1016/j.hep.2003.09.012
Abstract
Patients with hepatitis C virus (HCV) infection have a greater risk of developing type 2 diabetes mellitus. However, the mechanism of this association is unclear. In this study, we examined the potential defects in upstream insulin signaling pathways in liver specimens obtained from nonobese/nondiabetic subjects with HCV infection. Fasting liver biopsy specimens were obtained from 42 HCV–infected subjects and 10 non–HCV–infected subjects matched for age and body mass index. Liver tissues were exposed to insulin and examined for the contents and phosphorylation/activation status of the upstream insulin signaling molecules by immunoprecipitation and Western blot analysis. HCV infection resulted in a trend toward a 2–fold to 3–fold increase in insulin receptor (IR) and insulin receptor substrate (IRS)–1 contents when compared with non–HCV. In contrast, insulin–stimulated IRS–1 tyrosine phosphorylation was decreased by 2–fold in HCV–infected subjects compared with non–HCV–infected subjects (P < .05). The observed reductions in IRS–1 tyrosine phosphorylation were accompanied by a 3.4–fold decrease in IRS–1/p85 phosphatidylinositol 3–kinase (PI3–kinase) association and a 2.5–fold decrease in IRS–1–associated PI3–kinase enzymatic activity (P < .05 vs. non–HCV). This was accompanied by a marked reduction in insulin–stimulated Akt phosphorylation without any alterations in mitogen–activated protein kinase (MAPK) phosphorylation. Cellular contents of the hepatic p85 subunit of PI3–kinase were comparable between HCV–infected and non–HCV–infected subjects. In conclusion, we found that (1) HCV infection leads to a postreceptor defect in IRS–1 association with the IR and (2) insulin signaling defects in hepatic IRS–1 tyrosine phosphorylation and PI3–kinase association/activation may contribute to insulin resistance, which leads to the development of type 2 diabetes mellitus in patients with HCV infection.Keywords
This publication has 49 references indexed in Scilit:
- Response to Fukui et al.Diabetes Care, 2002
- The Phosphoinositide 3-Kinase PathwayScience, 2002
- Correlation of Serum Leptin Levels With Insulin Sensitivity in Patients With Chronic Hepatitis-C InfectionDiabetes Care, 2002
- PI 3-kinase and its up- and down-stream modulators as potential targets for the treatment of type II diabetesFrontiers in Bioscience-Landmark, 2002
- Chronic hepatitis C virus infection without cirrhosis induces insulin resistance in patients with β-thalassaemia majorEuropean Journal of Gastroenterology & Hepatology, 2001
- SOCS Proteins: Negative Regulators of Cytokine SignalingThe International Journal of Cell Cloning, 2001
- Increased Risk of Type 2 Diabetes in Noncirrhotic Patients With Chronic Hepatitis C Virus InfectionMayo Clinic Proceedings, 2000
- High prevalence of diabetes mellitus among adult β-thalassaemic patients with chronic hepatitis CEuropean Journal of Gastroenterology & Hepatology, 1999
- Evidence for a link between hepatitis C virus infection and diabetes mellitus in a cirrhotic populationJournal of Hepatology, 1994
- A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye bindingAnalytical Biochemistry, 1976